Peptides DB
Research-centric peptide and protocol reference hub
Study 19 of 43Vasopressin literaturebiorxiv-preprint · Observational2026

Activation of Vasopressin Receptor 1A by Vasopressin Enhances Myometrial Smooth Muscle Cell Excitability by Inhibiting the Potassium Channel SLO2.1

AVP enhances excitability in myometrial smooth muscle cells by inhibiting potassium currents, which may influence uterine contraction dynamics.

Read at biorxiv-preprintAdd to compare

Where it sits

this study against the rest of the vasopressin corpus
9
Preclinical
30
Observational · this one
1
Open-label
2
Randomised
1
Reviews

Summary and findings

This study investigates the role of arginine vasopressin (AVP) in enhancing the excitability of myometrial smooth muscle cells (MSMCs) through the activation of vasopressin receptor 1A (AVPR1A). The research demonstrates that AVP inhibits SLO2.1-mediated potassium currents, reducing current amplitude to approximately 60% of control currents. The findings suggest a mechanism by which AVP enhances intracellular Ca²⁺ signaling in myometrial cells.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
SLO2.1-mediated potassium currents reduced to approximately 60% of control currents.2026

Abstract

The authors’ words, as biorxiv-preprint supplied them

Arginine vasopressin (AVP) increases excitability of myometrial smooth muscle cells (MSMCs) through Gαq-coupled AVP receptors. Although excitability requires membrane depolarization, the mechanisms linking AVP receptor activation to membrane depolarization and Ca²⁺ signaling are incompletely understood. Here, we show that AVPR1 is the predominant AVP receptor in primary MSMCs. In Xenopus oocytes, AVP signals through AVPR1 to inhibit SLO2.1-mediated potassium currents, reducing current amplitude to approximately 60% of control currents. Consistent with suppression of a hyperpolarizing conductance, AVP depolarized a myometrial cell line (hTERT-HM) and increased intracellular Ca²⁺ signaling. Analysis of Ca²⁺ dynamics revealed that the initial Ca²⁺ peak was largely preserved under conditions limiting extracellular Ca²⁺ entry, consistent with intracellular store release. Conversely, the oscillatory phase depended on extracellular Ca²⁺ influx and was reduced by SLO2.1 knockdown. Together, these findings support a model in which AVP preferentially signals through AVPR1A to inhibit SLO2.1, depolarize myometrial cells, enhance VDCC-dependent Ca²⁺ entry, and promote excitability, enhancing conditions for uterine contraction.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the Vasopressin corpus

BAcute colonic pseudo-obstruction with transient failure of oral desmopressin in adipsic arginine vasopressin deficiency.JCEM case reports · 2023 · n=1 · Not reported in abstract.HumanAEffect of Vasopressin Initiation Threshold on Septic Shock Mortality: The VASSPR Cluster Crossover Randomized Strategy Trial.JAMA · 2026 · Mortality at 28 days was 31.8% in the lower-threshold group vs 33.0% in the higher-threshold group, P=0.62.HumanDVasopressin in Septic Shock-Is Early the Right Question?JAMA · 2026—DEffect of Vasopressin Initiation Threshold on Septic Shock Mortality: Research Summary.JAMA · 2026reviewAImpact of a Capillary Refill Time–Guided Personalised Hemodynamic Resuscitation Protocol in Septic Shock in Low- and Middle-Income Countries: A Post Hoc Analysis of the ANDROMEDA-SHOCK-2 Trialbiorxiv-preprint · 2023 · n=1467 · Win ratio of 1.16 (95% CI 1.14–1.18) in LMICs.HumanBA corticopapillary Gdf15 response links maladaptive collecting duct remodeling to polyuria during lithium exposurebiorxiv-preprint · 2026 · Not reported in abstract.Human